Prescriptas Launches Deal Health-AI™ V1, Redefining Deal Qualification Software

Prescriptas Launches Deal Health-AI™ V1, Redefining Deal Qualification Software 

January 2026

Prescriptas today announced the launch of Deal Health-AI™ V1, an AI-powered platform designed to bring clarity, structure, and discipline to deal qualification.

With this launch, Prescriptas formally introduces Deal Qualification Management (DQM) — a new approach focused on continuously diagnosing and strengthening the health of sales opportunities.

Addressing the Gap in Pipeline Visibility

Sales organizations have long relied on CRM systems to track activity and pipeline movement. Yet many still struggle with:

• Late-stage deal slippage
• Inaccurate forecasts
• Limited visibility into deal risk

The issue is not a lack of data — it is a lack of visibility into deal quality.

Deal Health-AI™ was built to address this gap by shifting the focus from pipeline quantity to pipeline reality.

A New Way to Understand Deal Health

“Most sales tools tell you where a deal is in the process, but not whether it’s actually healthy,” said Neil Colstad, Founder and CEO of Prescriptas.

“Deal Health-AI changes that by diagnosing how well a deal is qualified, where risk exists, and what actions will materially improve the odds of winning.”

Introducing the Deal Health-MRI™

At the core of Deal Health-AI™ is an intelligent qualification engine that evaluates opportunities using structured, evidence-based inputs.

The platform produces a diagnostic output known as the Deal Health-MRI™, providing a clear view of:

• What’s working
• What’s missing
• Where risk exists
• What needs to happen next

This visibility is delivered early — before deals stall or fail.

From Subjective Forecasting to Evidence-Based Confidence

Deal Health-AI™ applies qualification-based scoring and business-defined rules to assign forecast confidence labels.

This enables sales teams to move beyond subjective judgment and toward objective, defensible forecasting decisions.

Leaders gain visibility into:

• The true strength of each opportunity
• The specific factors driving forecast risk
• The actions required to improve outcomes

Operationalizing Deal Qualification Management (DQM)

Deal Health-AI™ represents the first commercial implementation of Deal Qualification Management (DQM).

DQM is a disciplined approach to managing deal quality as an ongoing process — not a one-time step.

It complements CRM and analytics platforms by acting as a system of insight, focused on:

• Evidence-based qualification
• Deal readiness
• Execution clarity

Designed for Better Decision-Making

Unlike traditional sales enablement tools that focus on automation or activity tracking, Deal Health-AI™ is designed to improve decision-making across the sales organization.

From frontline sellers to sales managers and revenue leaders, it provides a consistent, structured view of what is real in the pipeline — and what is not.

Looking Ahead

Prescriptas believes Deal Qualification Management will become a foundational capability for modern sales organizations.

As sales environments grow more complex, the ability to accurately assess deal quality, reduce risk, and execute with confidence will define top-performing teams.

Availability

Deal Health-AI™ is now available. To learn more, visit Deal Qualification Software | Deal Health-AI™

About Prescriptas

Prescriptas is the creator of Deal Health-AI™, an AI-powered sales enablement platform designed to improve deal quality, forecast accuracy, and execution discipline. Prescriptas introduced Deal Qualification Management (DQM) to help sales organizations diagnose deal health, reduce risk, and win more consistently.